# Batch Risk of Bias Eval Report

This report contains an audit trace: explicit extracted evidence, model-provided rationales, and label comparisons. It does not include hidden chain-of-thought.

- Studies: 5
- Domains: 25
- Accuracy: 13/25 (52.0%)

## Summary

| PMID | Study | Correct | Accuracy | Seconds |
|---|---|---:|---:|---:|
| 19487623 | King 2009 | 3/5 | 60.0% | 57.32 |
| 20579848 | Palacios 2009 | 2/5 | 40.0% | 76.77 |
| 21775755 | Ziegler 2011 | 3/5 | 60.0% | 65.70 |
| 22928960 | Houry 2012 | 3/5 | 60.0% | 71.85 |
| 23148458 | Sheridan 2012 | 2/5 | 40.0% | 78.50 |

## Error Types

- under-called_due_to_missing_or_underused_evidence: 7
- over-inferred_from_sparse_reporting: 3
- blinding_outcome_type_or_role_confusion: 2

## 19487623 - King 2009

- Mode: strict
- Review context: none (0 chars)
- Article chars: 24566
- Extraction context chars: 12006
- Total seconds: 57.32

### Methodology Extraction

- `randomization_method`: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).
- `allocation_concealment_method`: Not reported
- `blinding_participants`: Not reported
- `blinding_personnel`: Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated.
- `blinding_outcome_assessors`: The evaluating clinician monitored efficacy and was blinded to adverse events. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial.
- `attrition_details`: 149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.
- `study_design`: Randomized controlled trial (parallel-group RCT)
- `additional_notes`: Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications. The trial was registered (NCT00086645) and conducted at 6 academic medical centers; institutional review boards approved the study. All efficacy and safety analyses used the intent-to-treat principle.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Allocation concealment | Unclear risk | Unclear risk | yes |  |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: The report explicitly states a random component (permuted blocks with randomly varying block sizes stratified by site and age), which satisfies the criteria for adequate random sequence generation and indicates low risk of selection bias from sequence generation.
- Model support: Quote: "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)." Comment: This describes a random component (permuted block randomization with randomly varying block sizes), so sequence generation was probably done appropriately (Probably done).
- Model support context: [{"source": "methodology", "quote": "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).", "relevance": "Explicit description of a random sequence generation method (permuted blocks with random block sizes) meeting Cochrane criteria for low risk."}, {"source": "methodology", "quote": "Randomized controlled trial (parallel-group RCT)", "relevance": "Confirms trial design consistent with use of formal randomization procedures."}]
- GT support: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: Although the trial reports an adequate randomisation scheme, there is no information on the mechanism used to conceal allocations prior to assignment. Because concealment is not described, we cannot determine whether investigators could foresee assignments, so the risk of bias is unclear.
- Model support: Comment: Allocation concealment method not reported in the article; randomisation scheme described but no details on how allocation was concealed (e.g. central randomisation or sealed envelopes) — insufficient information to judge.
- Model support context: [{"source": "methodology", "quote": "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).", "relevance": "Describes the randomisation method but does not address how allocations were concealed from those enrolling participants."}, {"source": "methodology", "quote": "allocation_concealment_method: Not reported", "relevance": "Explicitly states that the method used to conceal allocation was not reported, which is key to assessing risk of selection bias."}, {"source": "methodology", "quote": "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.", "relevance": "Describes placebo matching and pharmacy preparation but does not indicate whether pharmacy-controlled or central...
- GT support: Details not provided
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study used a sensory-matched placebo and explicitly states clinicians were masked; therefore blinding of participants and personnel was probably effective and unlikely to have influenced outcomes (low risk of performance bias).
- Model support: Quote: "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications." Comment: Blinding of participants and treating staff was implemented by using a matched placebo; evaluating clinicians were masked. Probably done — blinding appears adequate and unlikely to have been broken.
- Model support context: [{"source": "methodology", "quote": "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.", "relevance": "Direct evidence that participants (and likely personnel administering medication) received visually/sensorily matched placebo, supporting effective blinding of participants and treating staff."}, {"source": "methodology", "quote": "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated.", "relevance": "Indicates that outcome assessors and clinicians were masked, reducing risk of performance bias."}]
- GT support: Two masked clinicians met with participants during each scheduled evaluation
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial explicitly states that evaluating clinicians who measured efficacy outcomes were blinded and trained on the scales, and placebo was matched, making it unlikely that outcome measurement was influenced by knowledge of intervention; therefore risk of detection bias is low.
- Model support: Quote: "The evaluating clinician monitored efficacy and was blinded to adverse events. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial." Comment: Blinding of outcome assessment was implemented for efficacy outcomes (evaluating clinicians were masked and trained), so detection bias is unlikely. Probably done.
- Model support context: [{"source": "methodology", "quote": "The evaluating clinician monitored efficacy and was blinded to adverse events. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial.", "relevance": "Direct statement that outcome assessors (evaluating clinicians) were blinded and trained for the specified efficacy measures, addressing detection bias."}, {"source": "methodology", "quote": "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.", "relevance": "Placebo matching supports maintenance of blinding across participants and staff, reducing chance that assessors learned allocation."}]
- GT support: The evaluating clinician monitored efficacy and was blinded to AEs
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Attrition was modest (≈17%), reasons for dropout (adverse events, withdrawn consent) were similar and balanced between groups, and an appropriate intention-to-treat approach with imputation (LOCF) was used, making material bias from incomplete outcome data unlikely.
- Model support: Quote: "149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward." Comment: Missing data were relatively low (≈17%), balanced across groups with similar reasons, and were handled with LOCF imputation; therefore risk of bias from incomplete outcome data is likely low.
- Model support context: [{"source": "methodology", "quote": "149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.", "relevance": "Provides the numbers and reasons for attrition, balance across groups, and the method used to handle missing data (LOCF)."}]
- GT support: LTFU citalopram: 13 withdrew, 1 due to serious AE; 8 AEs; 2 protocol violations; 2 consent withdrawn LTFU placebo: 13 withdrawn, 7 AEs; 1 protocol violation; 5 consent withdrawn
- Evidence row: {}
- Source context preview: 


## 20579848 - Palacios 2009

- Mode: strict
- Review context: none (0 chars)
- Article chars: 25127
- Extraction context chars: 12003
- Total seconds: 76.77

### Methodology Extraction

- `randomization_method`: Not reported
- `allocation_concealment_method`: Not reported
- `blinding_participants`: We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans.
- `blinding_personnel`: Measurements were taken ... by the CRC-trained personnel, who were blinded to the study treatments.
- `blinding_outcome_assessors`: Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments.
- `attrition_details`: Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. They were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost...
- `study_design`: Randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial; single-center parallel-group RCT, 21 weeks.
- `additional_notes`: Interventions: high dairy group instructed to consume four daily servings of dairy products provided monthly; high elemental calcium group instructed to consume usual diet plus a calcium supplement of 600 mg/d (calcium carbonate); control group instructed to consume usual diet plus a placebo tablet. Compliance monitored with monthly calendar, food records, FFQ, and 24-h recalls. Dietary and physical activity instructions aimed to maintain isocaloric intake and usual activity. No description...

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Unclear risk | Low risk / Not applicable | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk / Not applicable | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Not applicable / Unclear risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The article indicates random allocation occurred but does not describe any random component (e.g., computer generator, random number table) nor any non-random method; insufficient detail prevents judging it as low risk, so the appropriate judgement is Unclear risk.
- Model support: Comment: The report states only that subjects "were randomly assigned to one of the three treatments" but provides no description of the method used to generate the allocation sequence.
- Model support context: [{"source": "methodology", "quote": "They were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control.", "relevance": "Confirms that randomization was performed but gives no details on the random sequence generation method."}, {"source": "methodology", "quote": "No description provided of random sequence generation or allocation concealment procedures.", "relevance": "Explicitly notes absence of information on how the random sequence was generated, which is necessary to judge risk for this domain."}]
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated"
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Because the study report provides no details on the method used to conceal allocations prior to assignment, there is insufficient information to determine whether those enrolling participants could foresee upcoming allocations; under Cochrane criteria this warrants an unclear risk judgement.
- Model support: Comment: The report does not describe the method used to conceal allocation (no central randomization, sealed envelopes, or other procedures are reported), so it is unclear whether assignment could be foreseen by those enrolling participants.
- Model support context: [{"source": "methodology", "quote": "No description provided of random sequence generation or allocation concealment procedures.", "relevance": "Directly indicates absence of detail about allocation concealment in the report."}, {"source": "methodology", "quote": "They were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control.", "relevance": "States that random assignment occurred but gives no information on how allocation was concealed, which is necessary to judge risk of selection bias."}, {"source": "methodology", "quote": "Randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial; single-center parallel-group RCT, 21 weeks.", "relevance": "Mentions blinding but does not address allocation concealment; blinding of participants/personnel is not a substitute for concealment."}]
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated and the allocation concealment was performed centrally"
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk / Not applicable
- Match: False
- Model rationale: Although assessors were blinded and the paper claims a double-blind design, the dairy arm was single-blinded and there is no clear description of who was blinded (participants vs personnel) or how blinding was preserved. Given the nature of the interventions and lack of detail, there is insufficient information to judge the risk of performance bias.
- Model support: Quote: "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans." Comment: The report states the trial was double-blind but also indicates the dairy group was single-blinded; CRC-trained personnel taking measurements were blinded. There is insufficient detail on who (participants, all personnel) was blinded for each intervention, and how blinding could have been maintained or broken (especially for a dietary/dairy intervention that is difficult to blind). Probably not enough information to judge whether lack of blinding could have influenced outcomes.
- Model support context: [{"source": "methodology", "quote": "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans.", "relevance": "States blinding status but indicates complexity: dairy group was only single-blinded, raising concerns about participant or personnel awareness."}, {"source": "methodology", "quote": "Measurements were taken ... by the CRC-trained personnel, who were blinded to the study treatments.", "relevance": "Indicates outcome assessors were blinded, which reduces detection bias for measured outcomes, but does not resolve performance bias from participants or other personnel."}, {"source": "methodology", "quote": "Interventions: high dairy group instructed to consume four daily servings of dairy products...
- GT support: Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric...
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk / Not applicable
- Match: True
- Model rationale: The report explicitly states that CRC-trained personnel who performed measurements were blinded to treatment allocation, so outcome measurement was unlikely to be influenced by knowledge of interventions; therefore detection bias is judged low risk.
- Model support: Quote: "Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments." Comment: Blinding of outcome assessment was implemented (CRC-trained personnel were blinded), so detection bias is unlikely. Probably done.
- Model support context: [{"source": "methodology", "quote": "Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments.", "relevance": "Direct statement that outcome assessors (CRC-trained personnel) were blinded to study treatments, indicating low risk of detection bias for measured outcomes."}, {"source": "methodology", "quote": "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans.", "relevance": "Overall description of blinding in the trial; notes single-blinding for the dairy group but confirms blinding procedures intended, supporting that assessors were blinded even if participant blinding varied."}]
- GT support: Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study." | Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr. Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study."
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Not applicable / Unclear risk
- Match: True
- Model rationale: Although total attrition (5/30, 17%) and reasons are reported, there is no information on how dropouts were distributed across the three groups or whether missing data were imputed/handled appropriately; without that, risk of bias from incomplete outcome data cannot be judged.
- Model support: Quote: "Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. They were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. Of the 25 subjects who completed the study, 20 were female and 5 were male. No further details on attrition by group or handling of missing data are reported." Comment: Missing outcome data are reported in total (5/30 dropped out) with reasons, but attrition by group and handling/imputation of missing outcomes are not reported, so it is unclear whether missingness could bias results.
- Model support context: [{"source": "methodology", "quote": "Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. They were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. Of the 25 subjects who completed the study, 20 were female and 5 were male. No further details on attrition by group or handling of missing data are reported.", "relevance": "Provides the only available attrition information: number randomized, number lost, and reasons, but lacks breakdown by randomized group and information on analysis or imputations."}]
- GT support: 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male. Within the ﬁve males, one was allocated to the high dairy group, two to the high calcium group, and two to the control group." Comment: attrition rates were 10% and 20% but relating to a small number of randomised participants (N = 10) in both groups | 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who...
- Evidence row: {}
- Source context preview: 


## 21775755 - Ziegler 2011

- Mode: strict
- Review context: none (0 chars)
- Article chars: 24371
- Extraction context chars: 12003
- Total seconds: 65.7

### Methodology Extraction

- `randomization_method`: Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six.
- `allocation_concealment_method`: The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.
- `blinding_participants`: randomized, double-blind, placebo-controlled ... film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance
- `blinding_personnel`: The trial was ... double-blind ... The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.
- `blinding_outcome_assessors`: Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners).
- `attrition_details`: Not reported
- `study_design`: multicenter, randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial
- `additional_notes`: Screened patients were assigned a unique five-digit number. Randomized patients were additionally assigned a four-digit randomization number at baseline. An interim analysis was performed as soon as the 2-year data of most subjects were available; decision rules described (stop if P < 0.005) and final analysis alpha adjusted to 0.0452 per Šidák. Block size stated as six but described as "undisclosed block size of six."

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | High risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The investigators explicitly state a randomization list was generated by the Biostatistics Department and that block randomization was used; this indicates a random component in sequence generation consistent with Low risk per Cochrane criteria.
- Model support: Quote: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six." Comment: The sequence was generated by a centralized biostatistics department using a randomization list with block randomization (block size six), which describes a random component and meets criteria for low risk. Probably done.
- Model support context: [{"source": "methodology", "quote": "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six.", "relevance": "Describes generation of the allocation sequence by a statistical department using a random list and block balancing — direct evidence of a random component."}, {"source": "methodology", "quote": "Randomized patients were additionally assigned a four-digit randomization number at baseline.", "relevance": "Supports that randomization and assignment numbers were used, consistent with a formal random sequence generation process."}]
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug ..."
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: While an independent randomization list and sealed emergency envelopes are reported, the methods do not provide sufficient detail to determine whether allocation was concealed from those enrolling participants (e.g. use of sequentially numbered, opaque, sealed envelopes or central allocation). Therefore risk of bias for allocation concealment is unclear.
- Model support: Comment: The report states that a randomization list was generated by the Biostatistics Department and that investigators and the monitor received sealed envelopes to enable decoding in case of emergency, but it does not describe how allocation was concealed at the time of enrolment (e.g. whether sequentially numbered, opaque, sealed envelopes or central allocation were used).
- Model support context: [{"source": "methodology", "quote": "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six.", "relevance": "Shows random sequence generation by an independent department, but does not by itself confirm concealment procedures at enrolment."}, {"source": "methodology", "quote": "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.", "relevance": "Mentions sealed envelopes for emergency decoding, but does not specify whether these (or other) envelopes were sequentially numbered, opaque, sealed for allocation concealment or whether central allocation was used."}]
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug, at distance of the centers the study took place"; "the random allocation was balanced using an undisclosed block size of six."
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study explicitly states it was randomized and double-blind with matching placebo tablets and sealed emergency code envelopes for investigators, and outcomes were assessed by trained personnel with centralized reading — making it unlikely that lack of blinding materially biased the outcomes.
- Model support: Quote: "randomized, double-blind, placebo-controlled ... film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance" Comment: Blinding of participants and trial personnel was implemented with matching placebo tablets; emergency sealed envelopes were provided to investigators/monitor for decoding. Probably done — unlikely that lack of blinding biased outcomes.
- Model support context: [{"source": "methodology", "quote": "randomized, double-blind, placebo-controlled ... film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance", "relevance": "Direct evidence that participants received identical-appearing placebo and active tablets, supporting adequate participant blinding."}, {"source": "methodology", "quote": "The trial was ... double-blind ... The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.", "relevance": "Shows investigators and personnel were blinded and that unblinding was controlled (only via sealed envelopes for emergencies)."}, {"source": "methodology", "quote": "Experienced, trained, and certified ... physicians evaluated the NIS and NSC. The nerve conduction, quantitative...
- GT support: Quote: "... matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance." Comment: trial described as double-blind.
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study explicitly implemented double-blinding with matched placebo and used trained/certified assessors plus centralized reading centers, making it unlikely that outcome assessment was influenced by knowledge of allocation; therefore detection bias is low.
- Model support: Quote: "The trial was ... double-blind, placebo-controlled ... film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance" Comment: Blinding of participants and personnel was implemented and outcome assessments (NIS, NSC, nerve conduction, QSTs, autonomic tests) were performed by experienced, trained and certified personnel with centralized Reading and Quality Assurance Centers, making it unlikely that knowledge of allocation influenced outcome measurement. Probably done.
- Model support context: [{"source": "methodology", "quote": "The trial was ... double-blind, placebo-controlled ... film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance", "relevance": "Demonstrates that blinding of participants and personnel was planned and that placebo matched active treatment."}, {"source": "methodology", "quote": "Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners).", "relevance": "Indicates use of trained, certified outcome assessors and centralized...
- GT support: Quote: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: High risk
- Match: False
- Model rationale: There is insufficient reporting about attrition or exclusions (numbers lost, reasons, or imputation/analysis methods). According to the RoB criteria, this lack of information necessitates an 'Unclear risk' judgement.
- Model support: Comment: No information reported on numbers lost to follow-up, reasons for missing outcome data, or how missing data were handled. Unable to determine whether missing outcome data could bias results.
- Model support context: [{"source": "methodology", "quote": "attrition_details: \"Not reported\"", "relevance": "Direct statement that attrition/missing outcome data were not reported, which prevents assessment of amount, reasons, balance or handling of missing data."}, {"source": "methodology", "quote": "multicenter, randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial", "relevance": "Provides trial design context but does not supply information on incomplete outcome data."}]
- GT support: More than 40% of participants discontinued intervention in both groups during the 4-year study. We do not know how many participants were lost before the outcomes at 2 years (our outcome of interest), and how many after the first 2 years. Most participants (454/460) were included in the ITT analysis, but the study authors did not report for how many they managed to measure the outcome, and for how many they used the last observation carried forward ("mean of weeks 191 and 192 or last available value after randomization"). Apparently, the proportion of dropouts and the causes of dropout were equally distributed among the 2 groups.
- Evidence row: {}
- Source context preview: 


## 22928960 - Houry 2012

- Mode: strict
- Review context: none (0 chars)
- Article chars: 20317
- Extraction context chars: 12006
- Total seconds: 71.85

### Methodology Extraction

- `randomization_method`: We used computer-generated randomization to assign new reviewers to either the intervention or control group.
- `allocation_concealment_method`: Not reported
- `blinding_participants`: All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors.
- `blinding_personnel`: Editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.
- `blinding_outcome_assessors`: Not reported
- `attrition_details`: Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees).
- `study_design`: Randomized controlled trial
- `additional_notes`: Participants were consecutive individuals newly added to reviewer ranks during the study period; there were no exclusion criteria. Outcomes (mean review quality rating score and slope in change in editor-assigned reviewer quality ratings) were calculated from review scores recorded contemporaneously within our editorial management software. Data analysis used linear mixed effect models with Stata 10. Sample size calculation was not performed; a 4-year consecutive sample was enrolled.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Blinding of outcome assessment: All outcomes | Unclear risk | Unclear risk | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Low risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The investigators explicitly state they used computer-generated randomization, which is a valid random method per Cochrane guidance, indicating low risk of bias from sequence generation.
- Model support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." Comment: This explicitly describes a random component (computer random number generator) for sequence generation. Probably done.
- Model support context: [{"source": "methodology", "quote": "We used computer-generated randomization to assign new reviewers to either the intervention or control group.", "relevance": "Direct statement that a computer-generated random sequence was used, meeting the Cochrane criteria for low risk in random sequence generation."}, {"source": "methodology", "quote": "Participants were consecutive individuals newly added to reviewer ranks during the study period; there were no exclusion criteria.", "relevance": "Context about how participants were enrolled prior to randomization, supporting that the random sequence would be applied to an appropriate sampling frame."}]
- GT support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group."
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Although sequence generation was computer-based and there is a statement that editors invited reviewers without knowledge of assignments, the trial does not report a specific allocation concealment mechanism (central allocation, sealed envelopes, etc.). This insufficient detail prevents judging concealment as adequate, so risk is unclear.
- Model support: Comment: allocation concealment method not reported; computer-generated randomization was used but no details on how assignments were concealed from those enrolling participants.
- Model support context: [{"source": "methodology", "quote": "We used computer-generated randomization to assign new reviewers to either the intervention or control group.", "relevance": "Shows random sequence generation but does not describe how allocations were concealed prior to assignment."}, {"source": "methodology", "quote": "allocation_concealment_method: Not reported", "relevance": "Explicitly indicates that the method of allocation concealment is not reported, preventing assessment of risk."}, {"source": "methodology", "quote": "Editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.", "relevance": "Suggests those enrolling may have been unaware of assignments, but lacks detail on the concealment mechanism (could be post hoc or organisational), so cannot be relied on as adequate reporting of concealment."}]
- GT support: Computer-generated randomization and only a senior editor was aware of who was to receive the intervention.
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Reviewers were blinded in routine peer-review processes and editors invited reviewers without knowledge of allocation; outcomes were editor-assigned scores recorded in software and unlikely to be influenced by participants' or personnel's knowledge of allocation, so performance bias is unlikely.
- Model support: Quote: "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors." Comment: Blinding of participants (reviewers) to authors was in place and editors invited reviewers without knowledge of allocation; outcomes (editor-assigned reviewer quality ratings) were recorded objectively in editorial software and unlikely to be influenced by reviewers knowing their group. Probably done.
- Model support context: [{"source": "methodology", "quote": "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors.", "relevance": "Indicates participants (reviewers) were blinded to authors and suggests typical journal procedures preserved blinding relevant to behaviour during review."}, {"source": "methodology", "quote": "Editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.", "relevance": "Suggests personnel (editors) performing invitations were not aware of group allocation, reducing performance bias from staff."}, {"source": "methodology", "quote": "Outcomes (mean review quality rating score and slope in change...
- GT support: Quote: "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups." Comment: personnel were blinded but unclear if participants were blinded.
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: Because the study does not report whether outcome assessors (editors assigning review quality ratings) were blind to group allocation and the outcomes are subjective editor-assigned ratings that could be influenced by knowledge of allocation, there is insufficient information to judge low or high risk.
- Model support: Comment: Blinding of outcome assessment not reported. Outcomes were editor-assigned reviewer quality ratings recorded in editorial software, but no information is given about whether editors assessing review quality were blind to reviewer group assignment.
- Model support context: [{"source": "methodology", "quote": "blinding_outcome_assessors: \"Not reported\"", "relevance": "Direct statement that blinding of outcome assessment was not reported."}, {"source": "methodology", "quote": "Outcomes (mean review quality rating score and slope in change in editor-assigned reviewer quality ratings) were calculated from review scores recorded contemporaneously within our editorial management software.", "relevance": "Describes the outcomes and that they were editor-assigned scores, which could be influenced by knowledge of group assignment if editors were not blind."}, {"source": "methodology", "quote": "Editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.", "relevance": "Indicates editors lacked knowledge at the invitation stage but does not confirm they remained blind when...
- GT support: Quote: "All reviews at Annals are routinely rated by editors for quality on a previously reported 5-point scale that has demonstrated moderate reliability and is comparable to the scale validated by van Rooyen." Comment: unclear if the editors were aware of allocation when assessing the reviews.
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The amount of missing data is small and described with reasons unlikely to be related to outcomes; the authors conducted an ITT analysis with similar results and returned outcome data are balanced across groups, so attrition is unlikely to introduce material bias.
- Model support: Quote: "Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees)." Comment: The authors report the number and reason for missing/ non‑received intervention, and state that an ITT analysis was performed with essentially identical results (data not shown). Missing outcome data are small (37 respondents with balanced groups) and reasons are unlikely related to the true outcomes, so attrition is unlikely to bias results (Probably done).
- Model support context: [{"source": "methodology", "quote": "Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees).", "relevance": "Provides numbers and reasons for missing data, indicates ITT was performed and that available data are balanced between groups."}]
- GT support: Quote: "per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)." Comment: 4 subjects in the intervention group did not receive the intervention and were excluded from the analysis. The researchers state that an ITT analysis "yielded essentially identical results" but the analyses are not included in the paper.
- Evidence row: {}
- Source context preview: 


## 23148458 - Sheridan 2012

- Mode: strict
- Review context: none (0 chars)
- Article chars: 34179
- Extraction context chars: 12003
- Total seconds: 78.5

### Methodology Extraction

- `randomization_method`: Randomization used computer-generated random numbers that were sealed in opaque envelopes.
- `allocation_concealment_method`: Randomization used computer-generated random numbers that were sealed in opaque envelopes.
- `blinding_participants`: "Men in the highway safety group viewed the highway safety video, but received no accompanying coaching session. ... Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)"
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: Not reported
- `attrition_details`: Not reported
- `study_design`: Randomized controlled trial (two randomized controlled trials combined); participants randomized within practices.
- `additional_notes`: Physicians were invited to attend a 1-hour educational session and asked to provide informed consent and join study. The patient intervention and surveys were delivered prior to appointments in a private room. Participants completed baseline, immediate post-intervention, and post-visit questionnaires; actual screening rates measured at 9 month follow-up. Data from two trials (different sites) were combined for analysis.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Low risk | Low risk | yes |  |
| Blinding of participants and personnel: All outcomes | High risk | Low risk | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Incomplete outcome data: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The investigators report use of computer-generated random numbers to generate the allocation sequence (a valid random method). This satisfies the Low risk criteria for random sequence generation.
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: This explicitly describes a random component (computer-generated random numbers) for sequence generation and indicates proper handling (sealed opaque envelopes). Probably done.
- Model support context: [{"source": "methodology", "quote": "Randomization used computer-generated random numbers that were sealed in opaque envelopes.", "relevance": "Direct statement that a computer random number generator was used for sequence generation, meeting the Cochrane criteria for low risk."}]
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study reports that computer-generated random numbers were sealed in opaque envelopes, which is an adequate method to conceal allocation from those enrolling participants and therefore constitutes low risk of selection bias.
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: Probably done — allocation concealment using sealed opaque envelopes prevents foreknowledge of assignments and meets Cochrane criteria for low risk.
- Model support context: [{"source": "methodology", "quote": "Randomization used computer-generated random numbers that were sealed in opaque envelopes.", "relevance": "Describes the allocation concealment method; sealed opaque envelopes are an accepted method for preventing foreseeability of assignments."}]
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: High risk
- Ground truth: Low risk
- Match: False
- Model rationale: Participants clearly received different, noticeable interventions and there is no evidence that participants or personnel were blinded; outcomes include patient-reported measures and behaviours likely influenced by awareness of group assignment, meeting criteria for high risk of performance bias.
- Model support: Comment: Participants in the intervention arms viewed specific videos (e.g. "Men in the highway safety group viewed the highway safety video, but received no accompanying coaching session...") and there is no report that participants or personnel (other than physicians being notified only of participation but not assignment) were blinded. Because participants and those delivering the intervention were aware of group assignment and outcomes include patient-reported decision-making and subsequent screening behaviour, lack of blinding is likely to have influenced outcomes.
- Model support context: [{"source": "methodology", "quote": "\"Men in the highway safety group viewed the highway safety video, but received no accompanying coaching session. ... Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)\"", "relevance": "Shows participants received visibly different interventions and physicians were not fully blinded to participation details, indicating lack of participant/personnel blinding."}, {"source": "methodology", "quote": "blinding_personnel: \"Not reported\"", "relevance": "Lack of reporting on personnel blinding suggests key personnel were likely not blinded."}, {"source": "methodology", "quote": "blinding_outcome_assessors: \"Not reported\"", "relevance": "No information on assessor blinding; combined with participant awareness increases risk that performance bias affected outcomes."}]
- GT support: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)." Although described as single‐masked in the study registration, due to the attention control intervention in the control groups, both participants and staff could be considered blinded.
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Because the study report does not provide any information on whether outcome assessors were blinded and outcomes include both self-reported and objectively measured screening rates, there is insufficient information to determine whether detection bias is likely; therefore judgement is Unclear risk.
- Model support: Comment: The report does not state whether outcome assessment was blinded. Allocation concealment and participant/physician notification details are given, but there is no information about who assessed outcomes (questionnaires and 9-month screening rates) or whether they were blinded, so insufficient information to judge risk of detection bias.
- Model support context: [{"source": "methodology", "quote": "blinding_outcome_assessors: \"Not reported\"", "relevance": "Directly indicates that the study report did not provide information on blinding of outcome assessors."}, {"source": "methodology", "quote": "Participants completed baseline, immediate post-intervention, and post-visit questionnaires; actual screening rates measured at 9 month follow-up.", "relevance": "Specifies that outcomes include patient-reported questionnaires and objective screening rates, but without assessor blinding information it is unclear whether detection bias could have affected results."}, {"source": "methodology", "quote": "\"Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)\"", "relevance": "Indicates physicians were unaware of group assignment, which may reduce risk for outcomes...
- GT support: Self‐reported outcome measures, therefore, low risk considering masking of participants.
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Because the report provides no information on missing outcome data, reasons for missingness, balance across groups, or any imputation methods, there is insufficient information to judge whether attrition could bias the results; therefore the risk is unclear.
- Model support: Comment: Attrition/exclusions not reported; no information on numbers lost to follow-up or reasons for missing outcome data.
- Model support context: [{"source": "methodology", "quote": "attrition_details: \"Not reported\"", "relevance": "Direct statement that no information on missing outcome data was provided, preventing assessment of amount, reasons, balance across groups or handling/imputation."}, {"source": "methodology", "quote": "Participants completed baseline, immediate post-intervention, and post-visit questionnaires; actual screening rates measured at 9 month follow-up. Data from two trials (different sites) were combined for analysis.", "relevance": "Indicates outcomes were measured over time including a 9-month follow-up where attrition could occur, but no reporting of follow-up completeness is provided."}]
- GT support: SeeFigure 1for reporting on missing data (only 2 participants in intervention group due to false inclusion)
- Evidence row: {}
- Source context preview: 

## Workflow Evolution Notes

- Inspect mismatches where prediction is `Unclear risk` but GT is `Low risk`: these usually mean retrieval or Stage 1 extraction missed a concrete methodological phrase.
- Inspect mismatches where prediction is `Low risk` or `High risk` but GT is `Unclear risk`: these usually mean the prompt is allowing too much inference from generic trial language.
- For blinding mismatches, add outcome-type cues to the prompt: self-report outcomes, objective outcomes, assessor-administered outcomes, and whether lack of blinding can materially affect the outcome.
- For allocation concealment mismatches, require the model to distinguish sequence generation from concealment before assignment.